NSE · CAPLIPOINT
Caplin Point Laboratories Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#352
of 5,072 stocks
▲ 91W
Peak #352 · 27 Sep 2026
Operating in Healthcare, Caplin Point Laboratories Limited remains firmly promoter-controlled, with promoters holding 71%, is growing revenue at a solid clip, and commands a premium earnings multiple.
Market Cap
21,546.76 Cr
P/E Ratio
33.61
P/B Ratio
5.93
ROE
17.89%
ROCE
21.96%
Dividend Yield
0.28%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 610.36 Cr | 600.16 Cr | 542.77 Cr | 534.04 Cr |
| Net Profit | 179.09 Cr | 172.88 Cr | 165.86 Cr | 160.23 Cr |
| EPS | 23.27 | 22.38 | 21.56 | 20.32 |
| Operating Profit | 225.41 Cr | 213.80 Cr | 204.09 Cr | 201.14 Cr |
Shareholding pattern
Promoter
70.57%
Public
29.43%
PUBLIC BREAKDOWN
FII
5.75%
DII
2.49%
MF (within DII)
2.03%
Individuals
16.00%
Mutual fund holdings
₹327.15
Cr total
53
Schemes
17
Fund Houses
₹327.15 Cr
Total Exposure
UTI Mutual Fund₹278.35 Cr (85.1%)
Nippon India Mutual Fund₹9.00 Cr (2.7%)
HDFC Mutual Fund₹8.30 Cr (2.5%)
Mirae Asset Mutual Fund₹7.91 Cr (2.4%)
Motilal Oswal Mutual Fund₹4.55 Cr (1.4%)
Others₹19.04 Cr (5.8%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 18 Sep 2026 | Dividend | Dividend - Rs 4 Per Share |
| 29 May 2026 | Dividend | Interim Dividend - Rs 4 Per Share |
| 12 Sep 2025 | Dividend | Dividend - Rs 3 Per Share |
| 30 May 2025 | Dividend | Interim Dividend - Rs 3 Per Share |
| 23 Sep 2024 | Dividend | Dividend - Rs 2.50 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.